Why a Catch and Kill Business Acquisition Can Be Damaging and What to Do About It
Recently Patrick Soon-Shiong, the billionaire biotech investor, was accused of “catching and killing” the drug Cynviloq to stop its progression to market. Research from Yale School of Management’s Song Ma and Florian Ederer, along with co-author Colleen Cunningham, investigates how catch and kill acquisitions may blunt innovation and ultimately be harmful to patients.
Related Posts
Financial Reporting Analyst Career Path: Salary, Role and Scope
Know more about the career path of a financial reporting analyst, including their salary, role and scope of the job.
Is Remote Work Capable of Controlling Inflation?
This Chicago Booth Review article examines the possibility that remote work could hold the potential of controlling inflation.
What Factors Influence Stock Returns the Most?
This Chicago Booth Review article discusses what factors that are responsible for impacting stock returns the most.
Which Companies’ Stocks are “Immune” to the Pandemic?
A new working paper co-authored by Berkeley Haas Prof. Ross Levine identifies why some companies are less affected by the pandemic.
Stocks Rise While COVID-19 Cases Rise Too
Preliminary research by Yale SOM’s Peter Schott, the Juan Trippe Professor of International Economics, and three co-authors, reveals that unexpected investor behavior is causing the stock market to recover while COVID-19 cases are on the rise.
The What, How, and Why of Stock Market Crashes
Yale SOM’s Robert Shiller examines how the stock market rise of the 1920s, the crash of 1929, and the Great Depression that followed came to be seen as a tale of recklessness and divine punishment—and how that narrative still shapes our understanding of the stock market, in his new book – NARRATIVE ECONOMICS: How Stories Go Viral and Drive Major Economic Events
